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Summary  17 
A genomic region in the pig chromosome 4 has been previously associated to higher 18 
viremia levels and lower weight gain following PRRSV infection. The region includes the 19 
marker WUR1000125, a G>A polymorphism next to a putative polyadenylation site in the 20 
3’ untranslated region (3’UTR) of the interferon-induced guanylate-binding protein 1 21 
(GBP1) gene. The protein encoded by GBP1 is a negative regulator of T-cell responses. 22 
We show here that GBP1 expression is lower in liver and tonsils of pigs carrying the 23 
WUR1000125-G allele, due to differential allele expression (allele A expression is 1.9-fold 24 
higher than allele G). We also show that the GBP1 gene has two active polyadenylation 25 
signals 421-bp apart and that polyadenylation usage is dependent on the WUR1000125 26 
genotype. The distal site is the most prevalently used in all samples but the presence of the 27 
A allele favours the generation of shorter transcripts from the proximal site. This is 28 
confirmed by a differential allele expression study in AG liver and tonsil samples. The 29 
interaction between WUR1000125 and other mutations identified in the 5’ and 3’UTR 30 
regions of this gene should need to be studied. In conclusion, our study indicates that the 31 
WUR1000125 mutation is associated to changes in the expression of the negative T-cell 32 
regulator GBP1 gene. However, the chromosome 4 locus for PRRSV viremia levels and 33 
weight gain contains a cluster of four other GBP genes that remain to be studied as 34 
candidate genes for this QTL.   35 
 36 
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Introduction 40 
The porcine reproduction and respiratory syndrome (PRRS) is one of the main clinical 41 
problems in pig production. Vaccines have proved unreliable to be a consistent approach to 42 
control the disease due to the high mutational rate of this virus. Consequently, it has been 43 
raised awareness that selection for resistant or tolerant pigs can be a solution to mitigate 44 
the negative impact of this virus on pig production. Recently, a major QTL at porcine 45 
chromosome SSC4 has been reported to affect both pig growth rate and response to 46 
American strains of PRRS virus (Boddicker et al. 2012). A group of 6 SNPs in perfect 47 
linkage disequilibrium captured 15.7% genetic variance for viremia levels and 11.2% for 48 
body weight gain after experimental infection. These polymorphisms are located in the 49 
interferon-induced guanylate-binding protein 1 (GBP1) gene, which has been associated to 50 
the control of the immune innate response to bacterial and viral infections in other species 51 
(Kim et al. 2011; Pan et al. 2012; Selleck et al. 2013). Among these 6 SNPs, 52 
WUR1000125 was selected as a tag SNP to evaluate the effect of alternate haplotypes. 53 
WUR1000125 is a G>A polymorphism which lay next to a putative polyadenylation site 54 
(AATAAA) in the 3’ untranslated region (3’UTR) of GBP1. Mutations in the 3’UTR 55 
region can potentially affect transcript stability, thus influencing protein synthesis rate. 56 
Moreover, alternative usage of polyadenylation sites is a well-reporter regulator of protein 57 
expression, influencing mRNA stability, transport and translation, generally through the 58 
loss and gain of regulatory motifs, including microRNA-binding sites (Barrett et al. 2012; 59 
Sun et al. 2012). In the present work we have analysed whether the WUR1000125 60 
mutation affects GBP1 mRNA expression by analysing total expression levels, allele-61 
specific expression, and polyadenylation site usage rate in liver and tonsils from pigs of 62 
different WUR1000125 genotypes. 63 
 64 
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Materials and Methods 65 
DNA and RNA samples 66 
Pig tissue samples were available in the lab at the time of this experiment. We used liver 67 
(n=42) and tonsil (n=13) samples from 42 Duroc pigs, collected upon slaughter and stored 68 
at -80ºC until analysis. Animals were all males from two batches of previous experiments 69 
developed under commercial conditions. Pigs in the same batch were from the same sex, 70 
and unit, and were slaughtered at the same age (100 days old, for batch one and 180 days 71 
old for batch 2). Within batch, pigs were selected from different litters to minimise parental 72 
relationship. Liver samples were collected from both batches while tonsils were collected 73 
only from pigs in batch 1. Genomic DNA was isolated from liver using standard protocols 74 
(Sambrook & Russell 2001). Total RNA was isolated with TRI-Reagent (Sigma-Aldrich) 75 
following the manufacturer’s indications. Nucleic acid concentration and purity was 76 
assessed by spectrophotometry with Nanodrop-100 and the integrity tested by 77 
electrophoresis in agarose gels.  78 
 79 
Retrotranscription 80 
Prior to retrotranscription, 1 ug of total RNA was digested with Turbo DNA-free DNase 81 
(Ambion, LifeTechnologies) as indicated by the manufacturers in order to eliminate any 82 
traces of genomic DNA. The first-strand cDNA synthesis was performed with the 83 
RevertAid reverse transcriptase (Fermentas, ThermoFisher) in 20 ul reactions containing  84 
1x buffer, 1mM dNTPs, 50 pmol random hexamers, 1 ul ribolock (Fermentas), 100U of 85 
enzyme and 1 μg of RNA. Reactions were incubated 10 min at 25ºC, 1h at 42ºC and 10 86 
min at 70ºC.  87 
 88 
5 
 
GBP1 expression levels by real-time quantitative PCR (qPCR) 89 
cDNA was diluted 1:10 in DEPC-treated H2O prior to qPCR analysis. Primers 90 
(Supplementary Table S1) for GBP1 and two reference genes, YWHAZ and RPL32, were 91 
designed with Primer3plus using the qPCR default parameters (Untergasser et al. 2007). 92 
For each gene, a standard curve was generated by amplifying serial dilutions of a control 93 
cDNA to check for linearity between initial template concentration and Ct values. 94 
Quantitative real-time PCR assays were carried out in triplicate in an ABI-7500 device 95 
(LifeTechnologies) in a final volume of 5 µl containing 1x Maxima SYBRgreen/ROX 96 
Master mix (Fermentas) and 200 nM of each primer. The following thermal profile was 97 
used for all reactions: 10 min at 95°C, 40 cycles of 15 s at 95°C and 1 min at 60°C, 98 
followed by a slow denaturation ramp from 60ºC to 95ºC to generate a dissociation curve 99 
to control the specificity of the amplified product. Cycle threshold (Ct) values were used as 100 
quantitation units. In order to quantify and normalise the expression data we used the ΔΔCt 101 
method (Yuan et al. 2006) using the geometric mean Ct value from the two reference 102 
genes and the GBP1 Ct values.  103 
 104 
WUR1000125 genotyping and allele-specific expression assays 105 
The WUR1000125 was genotype with a custom allelic discrimination assay 106 
(LifeTechnologies). Primers and probes are given in Supplementary Table S1. We 107 
followed the manufacturer’s protocol to set up the PCR reactions. Sequence Detection 108 
Systems software (SDS 2.0) was used to automatically collect and analyse the data and to 109 
generate the genotype calls. Allele-specific expression was analysed as in Lo et al. (2003). 110 
Briefly, genomic DNA from two homozygous pigs for WUR1000125, one with genotype 111 
AA and the other with genotype GG, were mixed at the following ratios: 8:1, 4:1, 2:1, 1:1, 112 
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1:2, 1:4, and 1:8 (AA:GG). Allelic discrimination assays were conducted as above and the 113 
Ct data was used to calculate, for each mixing ratio, the Ct(VIC)/Ct(FAM) ratio, where the 114 
VIC signal corresponds to the detection to the A allele and FAM to the detection of G. 115 
These data were used to generate a standard curve. The allelic discrimination assay was 116 
then run in heterozygous AG cDNA samples (liver= 9, from batch 1 and 2; tonsils=5, from 117 
batch 1) and the gene expression allele ratio was extrapolated by intercepting 118 
Ct(VIC)/Ct(FAM) ratio of each sample on the standard curve. Genomic DNA samples 119 
from the same heterozygous AG pigs were assayed in parallel as a control. 120 
 121 
3′-rapid amplification of cDNA ends (3'RACE) 122 
3’-end characterisation of the GBP1 mRNA was carried out as follows from total RNA of 123 
tonsils (AA=4; AG=4) and liver (AA=4; AG=4; GG=4), selected at random within each 124 
genotype from pigs in batch 1 (tonsils) and batch 2 (liver). Retrotranscription was 125 
performed from total mRNA as above but using an anchored Oligo(dT) primer 126 
(Supplementary Table S1) that included an extended adaptor sequence (UAP – for 127 
universal amplification primer). Samples were incubated at 42°C for 1 h and the reaction 128 
was terminated at 70°C for 10 min. All primers used in this study are detailed in 129 
Supplementary Table S1 and Supplementary Figure S1. To amplify the 3’ ends, PCR 130 
reactions were performed in 20 μl containing 0.4 μM of each primer (3’RACE_1/UAP) 131 
and 1 μl of cDNA. After an initial denaturation step at 94°C for 5 min, the reaction was 132 
performed for 1 cycle with 94ºC x 30 sec, 60ºC x 2 min and 72ºC x 2 min, followed by 30 133 
cycles of 94ºC x 30 sec, 60ºC x 40 sec and 72°C x 90 sec. The final extension was carried 134 
out at 72°C for 10 min. A nested reaction was performed using 1 μl from the first reaction 135 
(1:100 dilution), with 0.4 μM of each primer (3’RACE_2/UAP) under the same cycling 136 
conditions. Amplified PCR products were subjected to 1.2% agarose gel electrophoresis 137 
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and visualised with ethidium bromide staining. Distinct PCR bands were excised from the 138 
gel, purified using QIAquick Gel Extraction Kit (QIAgen) and sequenced. 139 
 140 
GBP1 polyadenylation usage ratio 141 
A PCR was conducted with a FAM-labelled forward primer (GBP1_fam) and two reverse 142 
primers (Supplementary Table S1 and Supplementary Figure S2), one located just 143 
downstream of the first polyadenylation site and which included a string of seven Ts 144 
(GBP1-SHORT_R) and a second one just downstream the first primer, which should only 145 
be present in transcripts using the second polyadenylation site (GBP1-LONG_R). Samples 146 
included total RNA from liver (AA=4; AG=4; GG=4) and tonsils (AA=3; AG=3), selected 147 
at random within each genotype from pigs in batch 1 (tonsils) and batch 2 (liver). The PCR 148 
was performed with 0.3 ul of cDNA retrotranscribed with an anchored OligodT (50 pmol), 149 
diluted 1:10 in DEPC-treated H2O using the same cycle conditions as described in the 150 
3’RACE section. The expected sizes for the two PCR products were 725 and 745 bp, 151 
respectively. Given the small length differences, the two products are expected to be 152 
amplified with the same efficiency. After PCR, 1 ul of each reaction was mixed with 10 ul 153 
of HI-DI Formamide (LifeTechnologies), denatured at 95ºC x 5 min and incubated on ice x 154 
2 min. The products were then solved in an ABI-3100 capillary electrophoresis system 155 
(LifeTechnologies). Peak identification and area under the curve were calculated with the 156 
DAx Data Acquisition and Data Analysis software. 157 
Additionally, in the heterozygous samples (liver=4; tonsils=3) the transcripts resulting 158 
from the alternative polyadenylation sites were amplified separately with primers 159 
qGBP1_F/GBP1-SHORT_R and qGBP1_F/GBP1-LONG_R. The A and G allelic 160 
contribution to each of the transcripts was measured using an allelic discrimination assay 161 
from PCR template diluted 1:100, as explained in the allelic-specific expression section. 162 
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 163 
GBP1 promoter and full 3’UTR amplification and sequencing 164 
Primers were designed with Primer3plus (Untergasser et al. 2007) to amplify and sequence 165 
the GBP1 proximal promoter (up to 1,100 bp upstream the +ATG) and the full exon 11, 166 
which includes the STOP codon and the 3’UTR sequence (Supplementary Table S1). PCR 167 
reactions were carried out in a Veriti thermocycler (LifeTechnologies) in a volume of 25 l 168 
containing 1x buffer, 200 μM dNTP mix, 2.0 mM MgCl2, 400 nM of each primer, 1U of 169 
Taq polymerase (BIOTOOLS) and 60 ng of genomic DNA. The thermal profile was as 170 
follows: initial denaturing step for 5 min at 95°C and then 35 cycles of 20 s at 95ºC, 30 s at 171 
60°C and 1.30 min 72ºC, finishing with 5 min at 72ºC. PCR products were solved by 172 
electrophoresis in a 1.2 % agarose gel and positive bands were purified with ExoSAPit 173 
enzyme kit (USB) and sequenced with the BigDye Terminator Sequencing kit v3.1 174 
(LifeTechnologies). Sequences obtained were edited using the Sequencing Analysis 175 
software (LifeTechnologies) and aligned with the ClustalW program (Chenna et al. 2003). 176 
Prediction of potential transcription factor-binding sites was performed with the 177 
TRANSFAC 8.3 database with the PROMO v2.0.3 tool (Messeguer et al. 2002) and the 178 
2014 JASPAR-CORE repository (Mathelier et al. 2014). The 3’UTR region was scanned 179 
for RNA structural and regulatory motifs using RegRNA (Huang et al. 2006). 180 
 181 
Statistical Analysis 182 
Variation of GBP1 expression was analysed in each tissue separately with a model 183 
including the batch and the WUR1000125 genotype. The least squares means of the 184 
genotypes were separated using the Tukey test. Allele-specific expression in AG samples 185 
was analysed within tissue as above in a model that include the batch, on the logit 186 
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transformation of the data, as these were closed percentages (Ros-Freixedes & Estany 187 
2014). Comparison of polyadenylation usage by genotype, and of allele contribution per 188 
transcript, was performed within tissue using a t-test based on the logit transformation of 189 
the data. All the analyses were performed with JMP Pro 11 (SAS Inst. Inc., Cary, NC) and 190 
differences were considered significant at p<0.05. 191 
 192 
Results 193 
The genotype of the WUR1000125 mutation is associated to GBP1 expression 194 
GBP1 expression levels were measured in liver and tonsils of pigs with genotypes AA, AG 195 
and GG for the WUR1000125 SNP marker, which is located at the 3’UTR of the GBP1 196 
gene. Expression of GBP1 was lower in the liver of pigs with the GG genotype as 197 
compared to AA (p<0.01) pigs (Figure 1). Expression of heterozygous AG liver samples 198 
were intermediate to the alternative homozygotes. In a subset of these animals, for which 199 
tonsils were available, we also observed higher expression of GBP1 in AA pigs than in AG 200 
animals (p<0.05). No GG pig could be analysed for this tissue.   201 
 202 
The expression of the WUR1000125 marker is allele-specific 203 
Differential allele expression was assessed in liver and tonsils of heterozygous AG animals 204 
(Figure 2). In both tissues, allele A was expressed at higher levels (about 1.9-fold) than 205 
allele G (p<0.001). Presence of A and G alleles in controls of genomic DNA from AG pigs 206 
gave approximately a 50% ratio, as expected.  207 
 208 
The GBP1 gene has two active polyadenylation signals 209 
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Amplification of the 3’ end of the GBP1 mRNA indicated the presence of two main 210 
transcripts differing approximately 400 nt (Supplementary Figure S2). The two transcripts 211 
were detected in all samples analysed, which included liver from AA, AG and GG pigs and 212 
tonsils from AA and AG animals. PCR bands corresponding to the short and long 213 
transcript were subsequently sequenced to investigate the differences in size. Sequence 214 
alignment and analysis indicated that the two transcripts differed in length due to the 215 
alternative use of two active polyadenylation sites 421-bp apart. The full 3’UTR of the two 216 
transcripts were 603- and 1029-nt long. The A and G alleles were identified in the 217 
sequences of both long and short transcripts.  218 
Transcription termination and start of polyadenylation took place 17 and 16 nt after the 219 
proximal and distal polyadenylation sites, respectively (Supplementary Figure S2).  220 
The analysis of the sequence also revealed the presence of other polymorphisms in phase 221 
to the WUR1000125 in this fragment of the 3’UTR of the gene (Supplementary Figure S2) 222 
which are explained in more detailed below. 223 
Polyadenylation usage is dependent on the WUR1000125 genotype 224 
The WUR1000125 polymorphism lays 1-bp upstream of the first polyadenylation site. We 225 
next questioned whether the WUR1000125 polymorphism affected the rate of 226 
polyadenylation site usage. In order to test this, we carried out a modification of the 227 
3’RACE protocol with a common FAM-labelled forward primer in exon 10 and two 228 
reverse primers in exon 11 that were specific for the short or the long transcripts 229 
(Supplementary Figure S1). After amplification, fragments were solved by capillary 230 
electrophoresis and quantified as FAM fluorescent units (Figure 3). The distal 231 
polyadenylation site exhibited the highest usage rate in all samples analysed. On the other 232 
hand, the prevalence of the short transcript generated from the proximal polyadenylation 233 
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site differed across genotypes (p<0.05). In AA pigs, short transcripts represented a third of 234 
all the GBP1 mRNAs, both in liver and tonsils. The use of this proximal site was lower in 235 
AG pigs, representing 13% and 18% of total GBP1 mRNAs in liver and tonsils, 236 
respectively. The lowest usage rate of the proximal polyadenylation site was observed in 237 
the liver of GG pigs resulting in approximately 10-fold higher expression of long versus 238 
short transcripts (Figure 3).  239 
To further investigate this matter, the relative contribution of the A and G alleles to the 240 
total amount of short and long transcripts was investigated in liver and tonsil samples from 241 
AG pigs (Figure 4). Regarding the long transcripts, the ratio of A:G expression was similar 242 
to the allele-specific expression levels measured on total GBP1 mRNA (Figure 2). The A 243 
allele contributed to ~60% of the transcripts in all samples. In contrast, the short transcripts 244 
had a higher representation of the A allele (p<0.05 in liver; p<0.10 in tonsils), particularly 245 
in liver where it accounted for 74% of the mRNA polyadenylated at the proximal site 246 
(Figure 4).  247 
 248 
Description of other polymorphisms in the GBP1 regulatory regions  249 
The expression of GBP1 is induced by interferon (IFN)-α/β and IFN-γ, as well as tumour 250 
necrosis factor (TNF)-α and interleukin-1 (Naschberger et al. 2004). In the human gene, 251 
several cytokine-response elements have been described in the proximal promoter region 252 
as well as in the 5’UTR sequence in exon 1. These include GAS (γ-IF activation sites), 253 
ISRE (IFN-α stimulated response element) and an NFκB-binding motif. Additional in 254 
silico analysis of potential transcription-factor binding sites identified two putative 255 
overlapping sites for interferon regulatory factor (IRF-1) and NFκB (Supplementary Figure 256 
S3). GBP1 is a TATA-less promoter and, therefore, has several transcription start sites. We 257 
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sequenced 1,100 bp upstream of the ATG signal, which included the whole exon 1 and 258 
approximately 300-400 bp of promoter, in samples of pigs with AA and GG genotype for 259 
the WUR1000125 polymorphism. We identified a total of seven polymorphisms (six SNPs 260 
and a 1-bp INDEL) (Supplementary Table S2 and Supplementary Figure S3). None of the 261 
mutations changed the cytokine response elements described in this region but a SNP 262 
mutation at -631 bp co-localised with the putative overlapping IRF-1/NFκB regulatory 263 
elements (Supplemetary Table S3). 264 
We next sequenced the entire 3’UTR region to describe any additional mutations that 265 
might affect the stability of this region. We identified 10 SNP polymorphisms (including 266 
the WUR1000125 marker). We searched for 3’UTR structural and regulatory elements co-267 
localising with these mutations. The GBP1 3’UTR contains four interferon-response 268 
elements, three of which are common to the short and long transcripts (Supplementary 269 
Table S4). Three of the mutations identified lay in two of these regulatory elements 270 
(Supplementary Figure S4). In our sequencing data, the three mutations were fully linked 271 
to the WUR1000125 polymorphism.     272 
 273 
Discussion 274 
Several studies have reported differences in susceptibility to PRRSV infection and disease 275 
development between pig breeds (Reiner et al. 2010; Pena et al. 2013), but also within 276 
lines (Lewis et al. 2009). The genetic component of this has been confirmed by several 277 
authors (Lewis et al. 2009; Serao et al. 2014). Functional candidate genes for PRRSV 278 
susceptibility have been listed through global transcriptomics (Xiao et al. 2010; Arceo et 279 
al. 2012; Jiang et al. 2013) but only a few of them have been looked into in some more 280 
detail (Ren et al. 2012; Wang et al. 2012a; Wang et al. 2012b). The first genomic region 281 
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associated to response to PRRSV infection was reported in 2012 (Boddicker et al. 2012). 282 
Working with American commercial pigs, the authors identified a region in chromosome 4 283 
with six markers in perfect linkage associated to PRRSV viremia levels and weight gain. 284 
One of these markers, WUR1000125, was selected as a tag-SNP to further characterize the 285 
influence of this region on viremia profiles of experimentally-infected pigs. The 286 
WUR1000125 marker (SNPdb accession number rs80800372) is a G>A SNP 287 
polymorphism that lays in the 3’UTR of the GBP1 gene. Allele A, the unfavourable allele, 288 
is associated to higher PRRSV viremia levels and lower weight gain following infection 289 
(Boddicker et al. 2012). Conversely, the favourable G allele promotes lower plasma 290 
PRRSV titre levels and favours weight gain following a PRRSV challenge. In a previous 291 
study we have shown that the WUR1000125 marker segregates in European pig lines at 292 
allele frequencies similar to those described in American populations (Pena et al. 2013).  293 
The GBP1 gene encodes for an interferon-induced guanylate-binding protein belonging to 294 
the dynamin superfamily of large GTPases. This protein is an important player in cell-295 
autonomous immunity (MacMicking 2012), displaying  antiviral, antimicrobial and 296 
antiparasitic activity (Kim et al. 2011; Selleck et al. 2013; Zhu et al. 2013). Although 297 
interaction with several viral and microbial proteins have been postulated, the molecular 298 
mechanisms of action of GBP1 remained unknown until recent reports linking the action of 299 
this protein with the cytoskeleton remodelling that takes place in interferon-activated cells 300 
(Ostler et al. 2014). Moreover, GBP1 has been recently recognised as a negative regulator 301 
to T-cell activation (Forster et al. 2014), interfering with the early stage of T-cell receptor 302 
signalling through interaction with structural proteins.  303 
Given all the above, it is likely that the haplotype described by Boddicker et al. (2012) 304 
might affect the functionality of this gene. Using WUR1000125 as a tag-SNP, we show 305 
here that pigs carrying the favourable G allele express less GBP1 in liver and tonsils. The 306 
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lower mRNA levels are due to allele-specific differences in expression, with the A allele 307 
exceeding by approximately 1.9-fold the expression of the G allele. The differences of 308 
expression between alleles are comparable to the differences in expression between 309 
genotypes. Overall, the lower expression of the favourable G allele agrees well with the 310 
recent finding that GBP1 assists in tuning down T-cell responses (Forster et al. 2014). 311 
Genotypes associated to lower GBP1 expression are expected to exhibit more effective T-312 
cell responses. It is well-reported that a PRRSV-specific T lymphocyte IFN-γ response 313 
does not develop until at least 2 weeks after infection (Cecere et al. 2012). This cellular 314 
immune response is associated with an efficient immune response against this virus (Mateu 315 
& Diaz 2008). This fact highlights the relevance of efficient T-cell responses regarding the 316 
outcome of PRRSV infection.  317 
The length of the 3′UTR is a major determinant in mRNA expression (Barrett et al. 2012). 318 
In general, longer 3′UTRs correlate with a relatively lower expression level, as longer 319 
3′UTRs are more likely to possess miRNA binding sites and AU-rich elements that have 320 
the potential to promote mRNA decay and inhibit translation (Barrett et al. 2012). We 321 
show here that, in pigs, the GBP1 gene has two active polyadenylation signals. Alternative 322 
usage of polyadenylation sites is one of the mechanisms leading to changes in the 3’UTR 323 
length of mRNA transcripts. The WUR1000125 mutation is next to the more proximal 324 
polyadenylation site, therefore we have tested if WUR1000125 could be causal to the drop 325 
of expression by affecting the usage rate of the two polyadenylation signals. The usage of 326 
both signals was confirmed by 3’RACE characterisation of GBP1 in AA, AG and GG pigs. 327 
The three genotypes favoured the usage of the distal site both in liver and tonsils. 328 
Polyadenylation from the proximal signal was promoted mainly by the A allele, increasing 329 
the proportion of the shorter, potentially more-stable, transcripts by 4-fold in AA (36% of 330 
short transcripts) with respect to GG liver samples (~9%). The distribution of A and G 331 
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alleles among the longer transcripts paralleled the allele-specific expression results 332 
observed in the total GBP1 mRNA. However, and in agreement with the polyadenylation 333 
usage results, the shorter transcripts had a larger representation of A alleles both in liver 334 
and tonsils of heterozygous pigs. These shorter transcripts have potentially less capacity to 335 
be regulated by trans-factors in response to internal cues, such as changes in the immune 336 
state of the pig. Conversely, the G allele tends to accumulate in longer transcripts 337 
originated from the second polyadenylation site. The potentially lower stability of these 338 
mRNAs agrees with the lower GBP1 expression levels in pigs carrying the favourable G 339 
allele and is consistent with a model promoting the fine regulation of the GBP1 protein 340 
production. 341 
Taken together, these results strongly indicate that the WUR1000125 mutation change the 342 
processability of the proximal polyadenylation signal of the GBP1 gene. This can 343 
potentially be the cause of the differences in expression observed between genotypes, as 344 
the length of the 3’UTR influences the stability and the translation rate of the transcripts 345 
(Sun et al. 2012). Mutations in the gene promoter can also be responsible for differences in 346 
transcription levels. The WUR1000125 is in total linkage disequilibrium with other 347 
markers in the SSC4 chromosome (Boddicker et al. 2012). Our analysis of the GBP1 gene 348 
has identified 16 other polymorphisms in the 5’UTR and 3’UTR of this gene, most of 349 
which are also linked to this tag-SNP. Although none of the three functional IFN and 350 
NFκB response elements known in the promoter are affected by these mutations, a putative 351 
IFN regulatory element overlaps a SNP mutation at -631 bp from the start ATG codon. 352 
Moreover, three mutations in the 3’UTR of the GBP1 gene co-localise with two other 353 
IFNγ-response elements. The potential effect of these mutations on the expression of 354 
GBP1 cannot be overlooked and their possible interaction with the WUR1000125 marker 355 
should be explored in more detail. 356 
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In conclusion, our study indicates that the QTL for PRRSV viremia levels and weight gain 357 
described by Boddicker et al. (2012) is associated to changes in the expression of the 358 
negative T-cell regulator GBP1 gene. However, although the causal mutation responsible 359 
for this remains unknown, the results reported call attention to the transcriptional 360 
regulation of GBP1, a negative regulator of T-cell responses. Nevertheless, in the pig 361 
genome, GBP1 is within a cluster of five GBP genes (GBP1, 2, 4, 5 and 6). Further study 362 
of the other GBP genes might be of interest to help positioning the causal mutation. 363 
Moreover, it would be interesting to measure T-cell related cytokines in animals of AA and 364 
GG WUR1000125 genotype, to confirm the involvement of this genomic region with T-365 
cell activation and response. A further question that remains unsolved is how the function 366 
of this gene family relates to the enhanced growth rate reported in PRRSV-challenged pigs 367 
(Boddicker et al. 2012). Our own preliminary data (Pena et al. 2013) suggests that the 368 
relationship of GBP1 with growth rate depends on the epidemic phase of PRRS. While 369 
allele A is positively associated to growth in non-epidemic phases, allele G is, in contrast, 370 
enhancing weight gain during the epidemic phase or in challenged pigs. This hypothesis is 371 
further supported by the fact that the A allele, unfavourable for PRRSV viremia levels, is 372 
the most frequent in commercial populations selected for increased growth rate (Boddicker 373 
et al. 2012; Pena et al. 2013), with allelic frequencies in the range of 0.8-0.9. The 374 
contribution of this gene to growth gain in non-epidemic phases shall need to be assessed 375 
in the future. 376 
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Table 1. Pig tissue samples used in the experiment, distributed by WUR1000125 genotype 473 
 474 
  WUR1000125 genotype 
Tissue n AA AG GG 
Liver 42 20 16 6 
Tonsils 13 8 5 - 
 475 
  476 
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Figure 1. LS Means of GBP1 gene expression in liver and tonsils of Duroc pigs, by 477 
WUR1000125 genotype. Error bars represent standard errors. Within tissue, different 478 
letters indicate significant differences (p<0.05). 479 
 480 
 481 
  482 
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Figure 2: Allele-specific expression at the WUR1000125 polymorphism of the GBP1 gene 483 
measured in total RNA from liver and tonsils of heterozygous pigs and in genomic DNA as 484 
a control. Error bars represent the standard error of each mean. Within tissue, different 485 
letters indicate significant differences (p<0.05). 486 
 487 
 488 
 489 
  490 
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Figure 3. (A) Production of short and long transcripts by alternative use of proximal (pA1) 491 
and distal (pA2) polyadenylation sites in tonsil and liver samples from pigs with different 492 
genotype on the WUR1000125 marker of the GBP1 gene. Error bars represent the standard 493 
error of each mean. Within tissue and transcript, different letters indicate significant 494 
differences between genotypes (p<0.05). Quantification of short and long transcripts after 495 
capillary electrophoresis of FAM-labelled 3’UTR PCR products in an AA tonsil (B) and a 496 
GG liver (C) sample. 497 
 498 
 499 
 500 
 501 
  502 
(A) (B) 
(C) 
24 
 
Figure 4. Contribution of WUR1000125 alleles to the short and long transcripts of GBP1, 503 
generated by alternative use of proximal (pA1) and distal (pA2) polyadenylation signals, in 504 
liver and tonsil heterozygous AG pigs. Data represent percentage of allele contribution to 505 
each transcript. Within each tissue and allele, different letters indicate significant 506 
differences in transcript distribution (lowercase, p<0.05; uppercase, p<0.1). Error bars 507 
represent the standard error of each mean. 508 
 509 
  510 
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Supplementary Table 1. Primers and probes used in this study. 511 
 512 
Primer 5’3’ sequence Tm Position Amplicon size 
Gene expression experiment 
qGBP1_F TGGCTGAGAAGATGGAGAAG 58.1 E10 
97 bp 
qGBP1_R TCCTGAATTAGTCGGGCTTG 60.2 E11 
qYWHAZ_F TGATGATAAGAAAGGGATTGTGG 59.4 E3 
134 bp 
qYWHAZ_R GTTCAGCAATGGCTTCATCA  61.3 E4 
qRPL32_F CACCAGTCAGACCGATATGTCAA 61.1 E1 
70 bp 
qRPL32_R CGCACCCTGTTGTCAATGC 61.1 E2 
Genotyping and allele-specific assay 
gGBP1_F AGACCTAGAATCTCCACAGAATTTCCA 64.2 E11 
105 bp 
gGBP1_R GGAAAGGACAGTTCGCTTCTCTAG 62.7 E11 
Probe allele A VIC-CTGGGTGATAAATAAAT-NFQ  E11 
Probe allele G FAM-TGGGTGATGAATAAAT-NFQ  E11 
3’RACE 
Oligo(dT) ACTGGAAGAATTCTCGGCCGCAG (T)30VN    
UAP ACTGGAAGAATTCTCGGCCGCAG 70.3   
3’RACE_1 CTTCAGGAACAAGCCCGACT 62.8 E10-E11 1200-770 bp 
3’RACE_2 GACCAGAAGACCCTGAGCAC 61.2 E11 750-350 bp 
Polyadenylation usage ratio 
GBP1-fam FAM-CTTCAGGAACAAGCCCGACTA 65.1 E10  
GBP1-SHORT_R TTTTTTTTCGCTTCTCTAGCCCATT 64.8 E11 725 bp 
GBP1-LONG_R TCGAGCAGGAAAGGACAGTTC 62.9 E11 740 bp 
Promoter sequencing 
prmGBP1_F CCGGGATCTGGAGAGAACCT 63.9 Promoter 
1029 bp 
prmGBP1_R TTCACGGGAGGGTTTGACTG 64.5 E1 
Exon 11 sequencing 
GBP1e11_F GCCCGACTAATTCAGGAAGGA 63.6 E11 
1078 bp 
GBP1e11_R AGGGCTTTTGACAACTGCAA 61.9 E11 
 513 
  514 
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Supplementary Table S2. List of polymorphisms identified during the sequencing of the 515 
GBP1 promoter and 5’ and 3’UTR. Positions in promoter and 5’UTR are given in relation 516 
to the ATG START codon. Positions in the 3’UTR are counted from the TAA STOP 517 
codon. 518 
Polymorphism Change Position WUR100125 
AA pigs 
WUR1000125 
GG pigs 
5’UTR 
rs335275118 G>T -748 G T 
novel G>C -651 G G/C 
novel C>A -608 C C/A 
novel T>C -311 T C 
novel T>C -310 T/C C 
novel INDEL -307 delC C 
3’UTR 
rs339886073 G>T *445 G T 
rs80863339 G>A *540 A G 
rs342010514 C>T *544 T C 
novel A>G *545 G A 
rs80800372** A>G *580 A G 
rs324386096 T>C *610 T C 
novel G>C *718 C G/C 
novel G>T *742 G G/T 
novel A>T *743 A A/T 
rs323595619 T>C *859 T C 
**rs80800372 = WUR1000125 519 
 520 
 521 
  522 
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Supplementary Table S3. In silico analysis of putative transcription factor-binding sites 523 
in the proximal promoter and exon 1 of GBP1 gene, using PROMO and JASPAR tools. 524 
Sites potentially affected by polymorphisms found in the promoter region are highlighted. 525 
 526 
Supplementary Table S4. In silico analysis of the GBP1 3’UTR region for RNA-527 
regulatory motifs, using the Reg-RNA tool.  528 
  529 
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Supplementary Figure S1.  Location of primers used for the characterisation of GBP1 530 
3’UTR and polyadenylation usage rate experiments. (A) Structure of GBP1 in exons 531 
(boxes) and intron (lines) according to Ensembl (ENSSSCT00000007584). Coding 532 
sequences are filled in black and 5’ and 3’ regions in white. (B) Situation of START and 533 
STOP codons and proximal (PA1) and distal (PA2) polyadenylation signals in the mRNA. 534 
(C) Location of primers in relation to the short and long transcripts. Primer sequence and 535 
description is detailed in Supplementary Table S1. 536 
 537 
  538 
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Supplementary Figure S2. Characterisation of the 3’UTR region of the pig GBP1 539 
gene. (A) The 3’RACE experiment resulted in the amplification of two 3’UTR products 540 
in AA, AG and GG animals. MK – 100 bp ladder (HyperLadder, Bioline) (B) PCR 541 
fragments were sequenced and aligned. The two transcripts differed in the length of the 542 
3’UTR by the alternative use of two polyadenylation signals (in pink). Ten SNP 543 
polymorphisms (described in SNPdb, in blue; novel, in red) were also identified.   544 
 545 
 546 
(A) 547 
 548 
 549 
 550 
(B) 551 
 552 
Long-GG         GGACTGAGTCCGGCACGAGTTTGGTCAGGCCCACAACACATGCGAACATCGGGGACAACC 60 553 
Long-AA         GGACTGAGTCCGGCACGAGTTTGGTCAGGCCCACAACACATGCGAACATCGGGGACAACC 60 554 
Short-GG        GGACTGAGTCCGGCACGAGTTTGGTCAGGCCCACAACACATGCGAACATCGGGGACAACC 59 555 
Short-AA        GGACTGAGTCCGGCACGAGTTTGGTCAGGCCCACAACACATGCGAACATCGGGGACAACC 59 556 
                ************************************************************ 557 
 558 
Long-GG         CTTCTAGCTTCTCAGTGGAGGCAGCATCGTCTTCCACTGTTTCAAAACTGCCCAGTCTGT 120 559 
Long-AA         CTTCTAGCTTCTCAGTGGAGGCAGCATCGTCTTCCACTGTTTCAAAACTGCCCAGTCTGT 120 560 
Short-GG        CTTCTAGCTTCTCAGTGGAGGCAGCATCGTCTTCCACTGTTTCAAAACTGCCCAGTCTGT 119 561 
Short-AA        CTTCTAGCTTCTCAGTGGAGGCAGCATCGTCTTCCACTGTTTCAAAACTGCCCAGTCTGT 119 562 
                ************************************************************ 563 
 564 
   rs339886073 565 
Long-GG         CAGCAGTGATGGGATCCCTGGGCACTGGGAATGCGCGATGCTTACTGGTGAATTCGAAGC 180 566 
Long-AA         CAGCAGTGATGGGATCCCGGGGCACTGGGAATGCGCGATGCTTACTGGTGAATTCGAAGC 180 567 
Short-GG        CAGCAGTGATGGGATCCCTGGGCACTGGGAATGCGCGATGCTTACTGGTGAATTCGAAGC 179 568 
Short-AA        CAGCAGTGATGGGATCCCGGGGCACTGGGAATGCGCGATGCTTACTGGTGAATTCGAAGC 179 569 
                ****************** ***************************************** 570 
 571 
        rs80863339 rs342010514 572 
Long-GG         CAGAGCCAAGGCTCTTCTGGAGAGACCTAGAATCTCCACAGAATTTCCACAGGGAGACAG 240 573 
Long-AA         CAGAGCCAAGGCTCTTCTGGAGAGACCTAGAATCTCCACAGAATTTCCACAGGAAGATGG 240 574 
Short-GG        CAGAGCCAAGGCTCTTCTGGAGAGACCTAGAATCTCCACAGAATTTCCACAGGGAGACAG 239 575 
Short-AA        CAGAGCCAAGGCTCTTCTGGAGAGACCTAGAATCTCCACAGAATTTCCACAGGAAGATGG 239 576 
                ***************************************************** *** .* 577 
       rs80800372 = wur1000125  PA1        NOVEL 578 
Long-GG         AAAAACCATTAGCATGACTGGCAGCTGGGTGATGAATAAATGGGCTAGAGAAGCGAACTG 300 579 
Long-AA         AAAAACCATTAGCATGACTGGCAGCTGGGTGATAAATAAATGGGCTAGAGAAGCGAACTG 300 580 
Short-GG        AAAAACCATTAGCATGACTGGCAGCTGGGTGATGAATAAATGGGCTAGAGAAGCGAA--- 296 581 
Short-AA        AAAAACCATTAGCATGACTGGCAGCTGGGTGATAAATAAATGGGCTAGAGAAGCGAA--- 296 582 
                ********************************* ***********************    583 
  rs324386096 584 
Long-GG         TCCCTTCCTGCTCGATTCGCGCAGATTCTAACTTTACTAGGTGGGACTCTCTGGAATTTT 360 585 
Long-AA         TCCTTTCCTGCTCGATTCGCGCAGATTCTAACTTTACTAGGTGGGACTCTCTGGAATTTT 360 586 
Short-GG        ------------------------------------------------------------ 587 
Short-AA        ------------------------------------------------------------ 588 
                                                                             589 
MK    AA     AA    AA    AG    AG    GG    GG 
500 bp 
1000 bp 
30 
 
        NOVEL 590 
Long-GG         AGGTTACAGTGGACTACACAGTGACCTGAAAACAGTTTCCCATGGCGTTTGGGGCAATTT 420 591 
Long-AA         AGGTTACAGTGGACTACACAGTGACCTGAAAACAGTTTCCCATGGCGTTTGCGGCAATTT 420 592 
Short-GG        ------------------------------------------------------------ 593 
Short-AA        ------------------------------------------------------------ 594 
                                                                             595 
     NOVEL / NOVEL 596 
Long-GG         ACAGTCTGCAAAGAATTATGTGAAATGACAACAGAAACTGTGTTCGAAAACTGAGCTAAC 480 597 
Long-AA         ACAGTCTGCAAAGAAGAATGTGAAATGACAACAGAAACTGTGTTCGAAAACTGAGCTAAC 480 598 
Short-GG        ------------------------------------------------------------ 599 
Short-AA        ------------------------------------------------------------ 600 
                                                                             601 
 602 
Long-GG         TTAAGCGGCTAGACGGTTTAACCCTAGAGTTTAAGCTATCTTTTCCAAATTCTTCGCCAT 540 603 
Long-AA         TTAAGCGGCTAGACGGTTTAACCCTAGAGTTTAAGCTATCTTTTCCAAATTCTTCGCCAT 540 604 
Short-GG        ------------------------------------------------------------ 605 
Short-AA        ------------------------------------------------------------ 606 
                                                                             607 
   rs323595619 608 
Long-GG         CATACATAAAAACTTATTTTTGCCCTAGAGAATATGAATTGCTTTTGACATTTTTGCCCA 600 609 
Long-AA         CATACATAAAAATTTATTTTTGCCCTAGAGAATATGAATTGCTTTTGACATTTTTGCCCA 600 610 
Short-GG        ------------------------------------------------------------ 611 
Short-AA        ------------------------------------------------------------ 612 
                                                                             613 
 614 
Long-GG         GTTAAATAATGCTCTTGCTATTACTTAGTATATAGACTTTATTGCAGTTGTCAAAAGCCC 660 615 
Long-AA         GTTAAATAATGCTCTTGCTATTACTTAGTATATAGACTTTATTGCAGTTGTCAAAAGCCC 660 616 
Short-GG        ------------------------------------------------------------ 617 
Short-AA        ------------------------------------------------------------ 618 
                                                                             619 
        PA2 620 
Long-GG         TAGGTAAATGGGAAGACGATTAAGAGTATTTTCGAGCTGGAAATAAACTGTGCTTCACTG 720 621 
Long-AA         TAGGTAAATGGGAAGACGATTAAGAGTATTTTCGAGCTGGAAATAAACTGTGCTTCACTG 720 622 
Short-GG        ------------------------------------------------------------ 623 
Short-AA        ------------------------------------------------------------ 624 
                                                                             625 
 626 
Long-GG         AGCAAAAAAAAAAAAAAAAAAAA...CTGCGGCCGAGAATTCTTCCAGT  627 
Long-AA         AGCAAAAAAAAAAAAAAAAAAAA...CTGCGGCCGAGAATTCTTCCAGT  628 
Short-GG        ---AAAAAAAAAAAAAAAAAAAA...CTGCGGCCGAGAATTCTTCCAGT  629 
Short-AA        ---AAAAAAAAAAAAAAAAAAAA...CTGCGGCCGAGAATTCTTCCAGT  630 
                    631 
  632 
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Supplementary Figure S3. Characterisation of sequence variation in the promoter (in 633 
italics) and 5’UTR (exon 1) of the pig GBP1 gene. Underlined: In pink, two putative 634 
overlapping sites for interferon regulatory factor (IRF-1) and NFκB; in red, a putative p53 635 
binding element (human); in blue, a NFκB-binding motif; in green, ISRE (IFN-α 636 
stimulated response element). Polymorphic sites identified during the sequencing 637 
experiment are highlighter in black. Number on the right-hand side indicate bp from the 638 
ATG START codon in exon 2.  639 
 640 
CCGGGATCTGGAGAGAACCTTGTAACCATCTCCCTTTCTCCTCACTCCCCTCTTCCTCGT -1034 641 
CCAGGGCGAGAAAAAGCAGTGAGCTTAAGGGTAAACAGAGAATCAAATCTGTATCCACCT  -974 642 
CTGACGAGCTTGGTTGACAGGAACGGGCATCATCACCCACCCTCCTCATCATCACCCACC  -914 643 
CTCCACTGTAAGATGGAGACAGTCCCTCTTCTTTTGCCTGGTTCCGGTCAGGACTGAATT  -854 644 
GAACATTAACACAGGTAACTCTTAGAAAACAATCAAGACATAAAGCTGTGACTTCCCCTG  -794 645 
CTCTTTGGCAGACACAGAAAGGCAGTACAGTGAAGTCAGAAGGGTKTGAGATCAAGGATG  -734 646 
ATTTGGTTCAGATTATTTACAGGGCTGCGATGTGGGACAAGAGGGTACATTTTCTGTGCC  -674 647 
TTAGTTTCTACAAAACGATGGGSAAATGTTTGTTCTAAGTTATTGAACGCATGTAGAGCG  -614 648 
GTCAGMACAGAGCCTGGAACCTGAGCACAGGACATGCAGCCCCTTCCTGCGTGTGGGAAT  -554 649 
TAAGTTCCAGGGACTGTGTGTTCATGAAAGCGCCAGATCTGTCCTCTTCTTCACTGACCC  -494 650 
CACACATAAAGGAGGAGCCTGGTTCACTGTGAGGCCGTTTTTAAGGAAATTAAACTTAAA  -434 651 
GATGAGGAGGCTTCCTCATTCTAAATAGTTTTTCAAACAGACCCCAATCCTGAGATATAG  -374 652 
TCCATTATATTTAAACATCTAGTAGACATGTTTTAAAACAGCAAATGATCTCTAAGATCT  -314 653 
CTYSCCCCCCCCCCAAAAAAGAACGTGAAGATCATGCCAAATCCATTTACCTTCCTCCCA  -254 654 
GGATGGCTTTTAGAAATTCCTTTTATGGTTGTTGAGTCATTGCTTTGTATTCATTGCTTT  -194 655 
CAGTTTCATATTTATTCTAAGTCTATTACAGAGGTTGCTTTGCTTCTGACTCGGCTCTAG  -134 656 
AGGGAATCAGTAAAGCTCCTCGACACTGGCTGTGTGGACTAACAGTCAAACCCTCCCGTG   -74 657 
AAACAGAGAAGTTACAGAGAAGTCCACTCGTCTCACTGAGAAGAGGAAAGAACTCTCAAT   -14 658 
GAG -11 <[INTRON 1] 659 
  660 
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Supplementary Figure S4. Regulatory, structural and sequence variation analysis of the 661 
pig GBP1 3’UTR region. The sequence from the STOP codon (boxed in grey) in exon 11 662 
is indicated. Four interferon-response elements are underlined. The 10 SNP 663 
polymorphisms identified during the sequencing of the 3’UTR region are highlighted in 664 
black except the WUR1000125 mutation, which is highlighted in green. Numbers on the 665 
right-hand side indicate nucleotide positions from the TAA STOP codon. 666 
 667 
EXON11<TAAAGAACTGGAGAAGAGCGCTTTCCCGGTCCCGCTTAGCCATGGTCTTGCTCA  *51 668 
AGTAGTTTAGAATTAAGGAAAATGTTGCCAAACCTGATGATAATTACATTTCACATTGGT  *111 669 
ATTACACAAAGAACTCGCACATCACGCAGCAGGGTACCTGAAATCATCTCGACCTTCCTC  *171 670 
ACCACACCAAAGGGGGGACAGGATACGCATTTCACCTCTGCACCCGCCCAGATGGCACCA  *231 671 
CGGTCTGGTTCCAATCAGGAGCTTCCTCTTCCAGATGACCGCCAGCTAGACCAGAAGACC  *291 672 
CTGAGCACCGTCTCGGGACTGAGTCCGGCACGAGTTTGGTCAGGCCCACAACACATGCGA  *351 673 
ACATCGGGGACAACCCTTCTAGCTTCTCAGTGGAGGCAGCATCGTCTTCCACTGTTTCAA  *411 674 
AACTGCCCAGTCTGTCAGCAGTGATGGGATCCCGGGGCACTGGGAATGCGCGATGCTTAC  *471 675 
TGGTGAATTCGAAGCCAGAGCCAAGGCTCTTCTGGAGAGACCTAGAATCTCCACAGAATT  *531 676 
TCCACAGGAAGATGGAAAAACCATTAGCATGACTGGCAGCTGGGTGATAAATAAATGGGC  *591 677 
TAGAGAAGCGAACTGTCCTTTCCTGCTCGATTCGCGCAGATTCTAACTTTACTAGGTGGG  *651 678 
ACTCTCTGGAATTTTAGGTTACAGTGGACTACACAGTGACCTGAAAACAGTTTCCCATGG  *711 679 
CGTTTGCGGCAATTTACAGTCTGCAAAGAAGAATGTGAAATGACAACAGAAACTGTGTTC  *771 680 
GAAAACTGAGCTAACTTAAGCGGCTAGACGGTTTAACCCTAGAGTTTAAGCTATCTTTTC  *831 681 
CAAATTCTTCGCCATCATACATAAAAACTTATTTTTGCCCTAGAGAATATGAATTGCTTT  *891 682 
TGACATTTTTGCCCAGTTAAATAATGCTCTTGCTATTACTTAGTATATAGACTTTATTGC  *951 683 
AGTTGTCAAAAGCCCTAGGTAAATGGGAAGACGATTAAGAGTATTTTCGAGCTGGAAATA *1011 684 
AACTGTGCTTCACTGAGCTTTA *1071 685 
 686 
